Trials / Completed
CompletedNCT01529372
REnAL denervatIon by ultraSound Transcatheter Emission
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- ReCor Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The REALISE trial is a single-arm, open-label, prospective, post market evaluation to be conducted on twenty (20) eligible patients with a twelve month follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PARADISE percutaneous renal denervation | Intravascular ultrasound emission |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2012-02-08
- Last updated
- 2018-07-06
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT01529372. Inclusion in this directory is not an endorsement.